John Bellano

Chief Commercial Officer

Mr. Bellano has more than 25 years of experience in the Healthcare Industry.  Mr. Bellano started his career in Pharmaceuticals and transitioned to molecular diagnostics where he has spent the past 20 years of his career.  Most recently the Chief Commercial Officer of Sterilis Solutions   Prior to Sterilis Solutions he served as the commercial leader for Pharmacogenomic companies Assurex Health and AltheaDx.  While at Assurex Health (Myriad Genetics) revenue grew from $700k to a run rate of $100 Million during his 5 year span with the organization.  Assurex Health was acquired by Myriad Genetics for $425 Million in 2016.  Prior to Assurex Health,  Mr. Bellano served as VP sales for Molecular diagnostic company Third Wave Technologies, now Hologic.   With $32 million in revenue, Third Wave Technologies was acquired by Hologic for $580 Million in 2008.  He also worked for Roche Molecular and as public health specialist and was promoted to Regional Business Manager leading a $53 Million region in the Northeast.  Mr. Bellano has his degree in Marketing from DeSales University.